MAPT and Alzheimer disease: Early diagnosis of AD based on blood biomarkers has elicited increased attention in recent years, and many studies have shown that AD can be diagnosed by measuring quantitative blood biomarkers, such as Aβ40, Aβ42, T-tau, and P-tau181.